Department of Pediatrics, University of Washington School of Medicine, And Division of Nephrology, Seattle Children's Hospital, Seattle, WA, USA.
Semin Fetal Neonatal Med. 2020 Oct;25(5):101138. doi: 10.1016/j.siny.2020.101138. Epub 2020 Jul 12.
Hypertension in neonates is increasingly recognized because of improvements in neonatal intensive care that have led to improved survival of premature infants. Although normative data on neonatal blood pressure remain limited, several factors appear to be important in determining blood pressure levels in neonates, especially gestational age, birth weight and maternal factors. Incidence is around 1% in most studies and identification depends on careful blood pressure measurement. Common causes of neonatal hypertension include umbilical catheter associated thrombosis, renal parenchymal disease, and chronic lung disease, and can usually be identified with careful diagnostic evaluation. Given limited data on long-term outcomes and use of antihypertensive medications in these infants, clinical expertise may need to be relied upon to decide the best approach to treatment. This review will discuss these concepts and identify evidence gaps that should be addressed.
新生儿高血压由于新生儿重症监护的改进而日益受到重视,这使得早产儿的存活率得到提高。尽管新生儿血压的规范数据仍然有限,但有几个因素似乎对确定新生儿的血压水平很重要,尤其是胎龄、出生体重和产妇因素。在大多数研究中,发病率约为 1%,其识别取决于仔细的血压测量。新生儿高血压的常见原因包括脐导管相关血栓形成、肾实质疾病和慢性肺部疾病,通常可以通过仔细的诊断评估来识别。由于这些婴儿的长期结果和使用降压药物的数据有限,可能需要依靠临床专业知识来决定最佳的治疗方法。这篇综述将讨论这些概念,并确定应解决的证据差距。